Global Digital Diagnostics Market Size, Status and Forecast 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Digital Diagnostics Quarterly Market Size Analysis
- 2.1 Digital Diagnostics Business Impact Assessment - COVID-19
- 2.1.1 Global Digital Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Digital Diagnostics Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Digital Diagnostics Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Digital Diagnostics Headquarters and Area Served
- 3.3 Date of Key Players Enter into Digital Diagnostics Market
- 3.4 Key Players Digital Diagnostics Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Digital Diagnostics Segments, By Type
- 4.1 Introduction
- 1.4.1 HxM BT, HxM Smart, and BioHarness 3
- 1.4.2 BioStampRC
- 1.4.3 HealthPatch MD
- 1.4.4 IBrain
- 1.4.5 Intelligent Breast Exam (iBE)
- 1.4.6 Midmark IQvitals, IQecg, IQholter, IQspiro and Iqstress
- 1.4.7 Cerora Borealis
- 1.4.8 Qardioarm, Qardiobase, and Qardiocore
- 1.4.9 VitalPatch
- 1.4.10 Others
- 4.2 By Type, Global Digital Diagnostics Market Size, 2019-2021
5 Impact of Covid-19 on Digital Diagnostics Segments, By Application
- 5.1 Overview
- 5.5.1 Hospitals
- 5.5.2 Research Laboratories
- 5.5.3 Contract Research Organizations
- 5.5.4 Others
- 5.2 By Application, Global Digital Diagnostics Market Size, 2019-2021
- 5.2.1 By Application, Global Digital Diagnostics Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Biomeme
- 7.1.1 Biomeme Business Overview
- 7.1.2 Biomeme Digital Diagnostics Quarterly Revenue, 2020
- 7.1.3 Biomeme Digital Diagnostics Product Introduction
- 7.1.4 Biomeme Response to COVID-19 and Related Developments
- 7.2 Fever Smart
- 7.2.1 Fever Smart Business Overview
- 7.2.2 Fever Smart Digital Diagnostics Quarterly Revenue, 2020
- 7.2.3 Fever Smart Digital Diagnostics Product Introduction
- 7.2.4 Fever Smart Response to COVID-19 and Related Developments
- 7.3 Qardio
- 7.3.1 Qardio Business Overview
- 7.3.2 Qardio Digital Diagnostics Quarterly Revenue, 2020
- 7.3.3 Qardio Digital Diagnostics Product Introduction
- 7.3.4 Qardio Response to COVID-19 and Related Developments
- 7.4 MidMark Corp
- 7.4.1 MidMark Corp Business Overview
- 7.4.2 MidMark Corp Digital Diagnostics Quarterly Revenue, 2020
- 7.4.3 MidMark Corp Digital Diagnostics Product Introduction
- 7.4.4 MidMark Corp Response to COVID-19 and Related Developments
- 7.5 Cerora
- 7.5.1 Cerora Business Overview
- 7.5.2 Cerora Digital Diagnostics Quarterly Revenue, 2020
- 7.5.3 Cerora Digital Diagnostics Product Introduction
- 7.5.4 Cerora Response to COVID-19 and Related Developments
- 7.6 Neurovigil
- 7.6.1 Neurovigil Business Overview
- 7.6.2 Neurovigil Digital Diagnostics Quarterly Revenue, 2020
- 7.6.3 Neurovigil Digital Diagnostics Product Introduction
- 7.6.4 Neurovigil Response to COVID-19 and Related Developments
- 7.7 Medtronic
- 7.7.1 Medtronic Business Overview
- 7.7.2 Medtronic Digital Diagnostics Quarterly Revenue, 2020
- 7.7.3 Medtronic Digital Diagnostics Product Introduction
- 7.7.4 Medtronic Response to COVID-19 and Related Developments
- 7.8 UE LifeSciences
- 7.8.1 UE LifeSciences Business Overview
- 7.8.2 UE LifeSciences Digital Diagnostics Quarterly Revenue, 2020
- 7.8.3 UE LifeSciences Digital Diagnostics Product Introduction
- 7.8.4 UE LifeSciences Response to COVID-19 and Related Developments
- 7.9 Vital Connect
- 7.9.1 Vital Connect Business Overview
- 7.9.2 Vital Connect Digital Diagnostics Quarterly Revenue, 2020
- 7.9.3 Vital Connect Digital Diagnostics Product Introduction
- 7.9.4 Vital Connect Response to COVID-19 and Related Developments
- 7.10 MC10
- 7.10.1 MC10 Business Overview
- 7.10.2 MC10 Digital Diagnostics Quarterly Revenue, 2020
- 7.10.3 MC10 Digital Diagnostics Product Introduction
- 7.10.4 MC10 Response to COVID-19 and Related Developments
- 7.11 CellScope
- 7.11.1 CellScope Business Overview
- 7.11.2 CellScope Digital Diagnostics Quarterly Revenue, 2020
- 7.11.3 CellScope Digital Diagnostics Product Introduction
- 7.11.4 CellScope Response to COVID-19 and Related Developments
- 7.12 Oxitone Medical
- 7.12.1 Oxitone Medical Business Overview
- 7.12.2 Oxitone Medical Digital Diagnostics Quarterly Revenue, 2020
- 7.12.3 Oxitone Medical Digital Diagnostics Product Introduction
- 7.12.4 Oxitone Medical Response to COVID-19 and Related Developments
- 7.13 Sigma-Aldrich Corporation
- 7.13.1 Sigma-Aldrich Corporation Business Overview
- 7.13.2 Sigma-Aldrich Corporation Digital Diagnostics Quarterly Revenue, 2020
- 7.13.3 Sigma-Aldrich Corporation Digital Diagnostics Product Introduction
- 7.13.4 Sigma-Aldrich Corporation Response to COVID-19 and Related Developments
- 7.14 Bio SB
- 7.14.1 Bio SB Business Overview
- 7.14.2 Bio SB Digital Diagnostics Quarterly Revenue, 2020
- 7.14.3 Bio SB Digital Diagnostics Product Introduction
- 7.14.4 Bio SB Response to COVID-19 and Related Developments
- 7.15 Sakura Finetek Japan
- 7.15.1 Sakura Finetek Japan Business Overview
- 7.15.2 Sakura Finetek Japan Digital Diagnostics Quarterly Revenue, 2020
- 7.15.3 Sakura Finetek Japan Digital Diagnostics Product Introduction
- 7.15.4 Sakura Finetek Japan Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Digital Diagnostics, including the following market information:
Global Digital Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Digital Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Digital Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Digital Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Biomeme, Fever Smart, Qardio, MidMark Corp, Cerora, Neurovigil, Medtronic, UE LifeSciences, Vital Connect, MC10, CellScope, Oxitone Medical, Sigma-Aldrich Corporation, Bio SB, Sakura Finetek Japan, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
HxM BT, HxM Smart, and BioHarness 3
BioStampRC
HealthPatch MD
IBrain
Intelligent Breast Exam (iBE)
Midmark IQvitals, IQecg, IQholter, IQspiro and Iqstress
Cerora Borealis
Qardioarm, Qardiobase, and Qardiocore
VitalPatch
Others
Based on the Application:
Hospitals
Research Laboratories
Contract Research Organizations
Others